Examining the effects of price caps on insulin costs for diabetes patients
Official title: Measuring the Impact of Price Ceiling Controls: A Case Study of Insulin Out-of-Pocket Caps
Funded at University of Colorado Denver · NIH-11057379 · Data updated 2026-11-12
This study looks at how limiting the amount people have to pay for insulin helps diabetes patients, especially those from low-income and non-White backgrounds, get the medicine they need, and it hopes to show how this can improve their health and make it easier for them to stick to their treatment.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project start | September 1, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $99,999 |
| NIH project number | 1R03HS029960-01A1 |
| Project ID | NIH-11057379 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with type 1 or type 2 diabetes who are affected by high insulin costs.
✕Less likely to help
Patients who do not use insulin or those with diabetes who have adequate insurance coverage that fully covers their medication costs may not benefit from this research.
What this research studies
This research investigates how capping out-of-pocket costs for insulin affects diabetes patients' access to necessary medications. It focuses on the experiences of individuals with type 1 and type 2 diabetes, particularly those from low-income and non-White backgrounds who may struggle with insulin affordability. By analyzing data from states that have implemented these price ceilings, the study aims to understand the impact on medication adherence and overall health outcomes for diabetes patients. The findings could inform future policies aimed at improving insulin access and affordability.
Why it matters
Potential benefit: If successful, this research could lead to improved access to insulin for diabetes patients, enhancing their health outcomes and quality of life.
How similar studies have gone: Previous research has shown that price control measures can improve medication adherence and health outcomes, suggesting potential success for this approach.
Where this research is happening
-
University of Colorado Denver
Aurora, United States Active
Researchers
- Principal investigator: Distefano, Michael J — University of Colorado Denver
- Study coordinator: Distefano, Michael J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.